A randomized, open label, 4 period crossover study in healthy subjects to determine the effect of particle size on the pharmacokinetics of a single mg dose of GW856553.

Trial Profile

A randomized, open label, 4 period crossover study in healthy subjects to determine the effect of particle size on the pharmacokinetics of a single mg dose of GW856553.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Mar 2010

At a glance

  • Drugs Losmapimod (Primary)
  • Indications Atherosclerosis; Chronic obstructive pulmonary disease; Depressive disorders; Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 12 Mar 2010 Last checked against ClinicalTrials.gov record.
    • 28 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top